Calcitonin Gene-Related Peptide Terminates Long-Lasting Vasopressor Responses to Endothelin 1 In Vivo

No abstract is available for this paper.

• Publication year

  2011

• Venue

  HYPERTENSION

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.110.169128PMID 21606388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stimuli of Sensory-Motor Nerves Terminate Arterial Contractile Effects of Endothelin-1 by CGRP and Dissociation of ET-1/ETA-Receptor Complexes

  2010cited by this paper
• Endothelin receptors and pain.

  2009cited by this paper
• Autonomic neurotransmission: 60 years since sir Henry Dale.

  2009cited by this paper
• Calcitonin Gene-Related Peptide Selectively Relaxes Contractile Responses to Endothelin-1 in Rat Mesenteric Resistance Arteries

  2009cited by this paper
• Endothelin-1, an Endogenous Irreversible Agonist in Search of an Allosteric Inhibitor

  2009cited by this paper
• Functional Antagonism between Endogenous Neuropeptide Y and Calcitonin Gene-Related Peptide in Mesenteric Resistance Arteries

  2008cited by this paper
• Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

  2008cited by this paper
• The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy.

  2008cited by this paper
• Cerebral vasoconstriction after subarachnoid hemorrhage--role of changes in vascular receptor phenotype.

  2008cited by this paper
• The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

  2008cited by this paper
• Endothelin potentiates TRPV1 via ETA receptor-mediated activation of protein kinase C

  2007cited by this paper
• Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.

  2007cited by this paper
• Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2.

  2007cited by this paper
• Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease.

  2007cited by this paper
• The vascular endothelin system in hypertension--recent patents and discoveries.

  2006cited by this paper
• Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.

  2006cited by this paper
• Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP.

  2004cited by this paper
• Historical review: Endothelin.

  2004cited by this paper
• Vascular actions of calcitonin gene-related peptide and adrenomedullin.

  2004cited by this paper
• Vasodilator Reactivity to Calcitonin Gene-Related Peptide Is Increased in Mesenteric Arteries of Rats during Early Pregnancy

  2003cited by this paper
• Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism.

  2000cited by this paper
• Receptor‐ and non‐receptor‐mediated clearance of bigendothelin and endothelin‐1: differential effects of acute and chronic ETA receptor blockade

  2000cited by this paper
• Vanilloid (Capsaicin) receptors and mechanisms.

  1999cited by this paper
• Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.

  1998cited by this paper
• Cardiopulmonary effects of endothelin-1 in man.

  1997cited by this paper
• The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes.

  1997cited by this paper
• The capsaicin receptor: a heat-activated ion channel in the pain pathway

  1997cited by this paper
• Characterization of receptors mediating vascular responses to endothelin‐1 in the conscious rat

  1994cited by this paper
• Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

  1994cited by this paper
• Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.

  1994cited by this paper
• Clearance of circulating endothelin-1 by ETB receptors in rats.

  1994cited by this paper
• Endothelin-1 and -3 cause endothelium-dependent hyperpolarization in the rat mesenteric artery.

  1993cited by this paper
• In Vitro Biological Profile of a Highly Potent Novel Endothelin (ET) Antagonist BQ‐123 Selective for the ETA Receptor

  1992cited by this paper
• Different pharmacological profiles of big‐endothelin‐3 and big‐endothelin‐1 in vivo and in vitro

  1991cited by this paper
• Haemodynamic effects of human α‐calcitonin gene‐related peptide following administration of endothelin‐1 or NG‐nitro‐l‐arginine methyl ester in conscious rats

  1991cited by this paper
• Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.

  1990cited by this paper
• Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins.

  1990cited by this paper
• Tissue distribution and half-life of 125I-endothelin in the rat: importance of pulmonary clearance.

  1990cited by this paper
• Conversion of Big Endothelin‐1 to 21‐Residue Endothelin‐1 Is Essential for Expression of Full Vasoconstrictor Activity: Structure‐Activity Relationships of Big Endothelin‐1

  1989cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects.

  1986cited by this paper
• Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones.

  1985cited by this paper
• Possible site of the in vivo disposition of sodium nitroprusside in the rat

  1982cited by this paper
• Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

  1977cited by this paper

• Ocular neuromodulation as a novel treatment for retinitis pigmentosa: identifying rod responders and predictors of visual improvement

  2025cites this paper
• Alpha-Calcitonin Gene Related Peptide: New Therapeutic Strategies for the Treatment and Prevention of Cardiovascular Disease and Migraine

  2022cites this paper
• Delivery of astragalus polysaccharide by ultrasound microbubbles attenuate doxorubicin-induced cardiomyopathy in rodent animals

  2022cites this paper
• Efficacy of the lumbar sympathetic ganglion block in lower limb pain and its application prospects during the perioperative period

  2022cites this paper
• Endothelin System and Therapeutic Application of Endothelin Receptor Antagonists

  2021cites this paper
• Sympathetic and sensory-motor nerves in peripheral small arteries.

  2020cites this paper
• CGRP Receptor Signalling Pathways.

  2018cites this paper
• Delayed cardiomyocyte hypertrophic responses after brief exposure to endothelin-1 or phenylephrine

  2018cites this paper
• Transcerebral net exchange of vasoactive peptides and catecholamines during lipopolysaccharide-induced systemic inflammation in healthy humans.

  2018cites this paper
• Endothelin-1 Regulation of Exercise-Induced Changes in Flow: Dynamic Regulation of Vascular Tone

  2017cites this paper
• Endothelial dysfunction and vascular disease – a 30th anniversary update

  2017cites this paper
• Endothelin

  2016cites this paper
• Fasting serum CGRP levels are related to calcium concentrations, but cannot be elevated by short-term calcium/vitamin D supplementation.

  2015cites this paper
• Endothelin receptors, renal effects and blood pressure.

  2015cites this paper
• End o' the line revisited: moving on from nitric oxide to CGRP.

  2014cites this paper
• Role of 5-HT7 receptors in the inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.

  2014cites this paper
• Calcitonin gene-related peptide protects the myocardium from ischemia induced by endothelin-1: intravital microscopic observation and (31)P-MR spectroscopic studies.

  2014cites this paper
• Long-lasting physiological antagonism of calcitonin gene-related peptide towards endothelin-1 in rat mesenteric arteries and human coronary arteries.

  2013cites this paper
• Endothelin‐1 and endothelin‐2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries

  2013influential citation
• Endothelin, kidney disease, and hypertension.

  2013cites this paper
• Renal protective effects of α-calcitonin gene-related peptide in deoxycorticosterone-salt hypertension.

  2013cites this paper
• Sphingolipids in essential hypertension and endothelial dysfunction

  2013cites this paper
• Endothelin system: roles in hypertension

  2013cites this paper
• Chapter 189 – CGRP

  2013cites this paper
• Endothelin-1 and -2: two amino acids matter.

  2012cites this paper
• G‐protein βγ subunits in vasorelaxing and anti‐endothelinergic effects of calcitonin gene‐related peptide

  2012cites this paper
• Novel tyrosine kinase signaling pathways: implications in vascular remodeling

  2012cites this paper
• Endothelin in hypertension: an update

  2012cites this paper
• EndothelinA–EndothelinB Receptor Cross Talk in Endothelin-1–Induced Contraction of Smooth Muscle

  2012cites this paper
• Pharmacokinetic and pharmacodynamic properties of SOL1: a novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme.

  2012cites this paper
• Agonist‐dependent modulation of arterial endothelinA receptor function

  2012cites this paper
• GPCR models of pain in cardiovascular diseases: Contributions of kinins and endothelins

  2012cites this paper